Tesamorelin is a stabilized analog of human growth-hormone-releasing hormone. Its proposed mechanism is engagement of the GHRH receptor, supported by an N-terminal modification that improves stability relative to the native hormone. In model systems it behaves as a durable mimic of the endogenous GHRH signal.
GHRH-receptor engagement
The analog is proposed to bind the pituitary GHRH receptor, a class-B G-protein-coupled receptor, activating adenylate cyclase and raising intracellular cAMP in signaling associated with growth-hormone release in model systems. It belongs to the same GHRH-analog family as sermorelin and CJC-1295 DAC, all of which converge on the same receptor.
Stabilization chemistry
An N-terminal trans-3-hexenoyl modification is proposed to slow enzymatic degradation, particularly aminopeptidase cleavage at the exposed amino terminus. By protecting that vulnerable position, the cap extends the analog's usable window in research systems compared with unmodified GHRH fragments.
Full-length context
Retaining the full GHRH(1-44) backbone means the analog presents the complete native sequence to the receptor, rather than a truncated core. This full-length design is one way its mechanism is distinguished from shorter fragment-based tools.
Interpreting results
In-vitro concentrations are set by assay design and receptor pharmacology, not by any human dosing logic. Foundational context is in the tesamorelin overview, and secretagogue contrast is provided by ipamorelin.
Signal duration and pathway context
Stability changes the temporal window in which receptor engagement can be observed, but it does not create a new receptor pathway. Tesamorelin remains a GHRH-receptor ligand rather than a ghrelin-receptor secretagogue. Controlled comparisons between those classes can therefore separate receptor identity from signaling duration. Time-course measurements of receptor-proximal and downstream readouts are important, because a longer detectable response may reflect slower peptide loss rather than stronger intrinsic receptor activation.
Product page: Tesamorelin research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.